Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GPR101 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KCNJ6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIZ-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
DCAF11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SF3A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CASC22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C7orf25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM114A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF133 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUPV3L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930404 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCZ1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MSANTD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACOT12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927098 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXO5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR3681HG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on